From: Left ventricular support adjustment to aortic valve opening with analysis of exercise capacity
LVAD patients (n = 8) | |
---|---|
General Data | |
Age, years | 45 ± 13 |
Height, cm | 174 ± 6 |
Weight, kg | 75 ± 10 |
Body mass index, kg/m 2 | 24 ± 3 |
LVEF, % | 29 ± 11 |
Male | 8 |
Etiology of heart failure | |
Dilated cardiomyopathy | 6 |
Ischemic cardiomyopathy | 2 |
Medical treatment | |
ACE inhibitors | 7 (88%) |
ß-blockers | 7 (88%) |
Diuretics | 8 (100%) |
Aldosteron antagonists | 8 (100%) |
Angiotensin II antagonists | 2 (25%) |
Digoxin | 3 (38%) |
Warfarin | 8(100%) |
Aspirin | 8(100%) |
Clopidogrel | 4 (50%) |
LVAD support | |
Duration of LVAD support, days | 465 ± 257 |
Pump flow, L/min | 4 ± 0.3 |